Back to Search
DR. MICHAEL A COLUCCI M.D.
M.D.
Orthopaedic Surgery Physician
NPI: 1265492698IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
205530(NY)
Education
STATE UNIVERSITY OF NEW YORK AT BUFFALO SCHOOL OF MEDICINE
Class of 1992
Research & Publications (20)
Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins.
PMID 19377079·Haematologica·2009
8-other
Potent activity of indolequinones against human pancreatic cancer: identification of thioredoxin reductase as a potential target.
PMID 19364812·Mol Pharmacol·2009
7-preclinical
Modulation of human peripheral blood mononuclear cell proliferative response by diltiazem : in vitro comparison in younger versus older subjects.
PMID 19102517·Drugs Aging·2009
4-observational
Adenosine A1 and A3 receptor agonists inhibit nonadrenergic, noncholinergic relaxations in the guinea pig isolated trachea.
PMID 19077382·Respiration·2009
7-preclinical
The contribution of anti-Xa and anti-IIa activities to the profibrinolytic activity of low-molecular-weight heparins.
PMID 19350129·Thromb Haemost·2009
8-other
First evidence for an anxiolytic effect of a diterpenoid from Salvia cinnabarina.
PMID 19475986·Nat Prod Commun·2009
7-preclinical
New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation.
PMID 18508278·Pharmacol Res·2008
7-preclinical
Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation.
PMID 18562485·J Leukoc Biol·2008
8-other
Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: another potential mechanism of immune-suppression.
PMID 18289624·Toxicol Appl Pharmacol·2008
8-other
Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential.
PMID 18624976·J Thromb Haemost·2008
8-other
TAFI deficiency in liver cirrhosis: relation with plasma fibrinolysis and survival.
PMID 17915296·Thromb Res·2008
8-other
Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
PMID 18264564·Org Biomol Chem·2008
6-review
Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
PMID 17971996·Org Biomol Chem·2007
8-other
Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity.
PMID 17944451·J Med Chem·2007
8-other
Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells.
PMID 17455910·Biochemistry·2007
8-other
Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study.
PMID 17505032·Chest·2007
8-other
Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
PMID 18064315·Thromb Haemost·2007
4-observational
Tissue factor and vascular endothelial growth factor expression in colorectal cancer: relation with cancer recurrence.
PMID 17223937·Colorectal Dis·2007
8-other
Synthesis and evaluation of prodrugs for anti-angiogenic pyrrolylmethylidenyl oxindoles.
PMID 17254788·Bioorg Med Chem Lett·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 360 Linden Oaks Ste 100
Rochester, NY 14625 - Phone
- (585) 723-2845
Quick Facts
- NPI
- 1265492698
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile